Effect of Inhalation Therapy on Children's Fear and Anxiety Levels and Physiological Parameters

Launched by RECEP TAYYIP ERDOGAN UNIVERSITY · Jun 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how inhalation therapy can help reduce fear and anxiety in young children aged 3 to 6 who are receiving treatment for respiratory issues. The goal is to see if using a nebulizer, which is a device that turns liquid medicine into a mist for easy breathing, can not only improve children's physical symptoms but also make them feel more comfortable and less scared during treatment. The study will take place at Recep Tayyip Erdogan University Training and Research Hospital from July 2023 to July 2025 and will involve 120 children and their mothers who meet specific criteria and agree to participate.

To be eligible for the trial, children must be between 3 and 6 years old, be receiving nebulizer treatment for a respiratory condition, and not have any significant mental or neurological disabilities. It’s important that the child's mother is present during the treatment and can communicate in Turkish. Participants will fill out simple questionnaires to help researchers understand their experiences. Mothers and children will also interact with fun toys during the treatment to help reduce anxiety. This study aims to create a more positive experience for children during medical procedures, and your participation could contribute to valuable insights in this area!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Having a child between the ages of 3-6
• • Nebulizer and inhaler treatment will be applied
• • The child does not have a mental or neurological disability
• • Applying due to respiratory system disease
• • The presence of the child's mother during the application period
• • Mother and child can speak Turkish
• • The mother does not have any obstacle to communication
• • Mother's literacy
• • Parent and child volunteering to participate in the research.
• Exclusion Criteria:
• • The child and parent have previously experienced inhalation therapy with a nebulizer.
• • The child is hyperthermic (body temperature is 38 C and above)
• • The child has pain,
• • The child is in the terminal period,
• • The parent has a condition that prevents him/her from evaluating the scale (mental disability, etc.).